紐英崙玉山科協 - 南加玉山 從信息時代到智能AI時代 8/13

南加玉山科技協會主辦, 南加TECO科技組協辦
Time:  8/13 6PM 美西時間, 8PM 美東時間,
           8/14, 9AM 台灣時間
請在此報名: https://www.eventbrite.com/e/from-information-age-to-intelligent-era-tickets-162778014423
座談會將在 YouTube 線上直播 https://www.youtube.com/watch?v=PNMbnurm5yg

主題： From Information Age to Intelligent Era
（從信息時代到智能AI時代）

前科技部政務次長許有進曾在美國矽谷就業及成功創業。在次長任內推動法規鬆綁、除了促成「台灣科技新創基地（TTA）」的成立，還透過建構AI主機、設立AI創新研究中心、打造智慧機器人、半導體射月計劃與科技大擂台等五大策略，促成台灣產業智慧轉型AI化。

他將簡要談談他從2017年起在科技部主導的 AI 和人工智能半導體設計方面的計劃。在座談會中，他預計人工智能和未來大數據將應用到各行各業。他也會觸及一些國際公司對技術的預測，分享一些最近提出的創新想法。他相信更多巧妙的想法正在開發之中來處理面對這個新時代的新挑戰。

主持人：
俞寧寧（Ning Ning Yu),  南加玉山科技協會理事長

 

Let’s get together We’re hosting a new event, and we’d love to see you there. Join us for BIO Digital Taiwan Day, June 22, 2021 at 7:00 PM. Keynote Speaker: David K Lee Chief Executive Officer of Servier Pharmaceuticals David K. Lee is the CEO of Servier Pharmaceuticals and a seasoned veteran of the pharma industry dedicated to bringing innovative, responsible and life-changing products to patients around the globe. As CEO, David leads Servier Pharmaceuticals’ efforts to leverage Servier Group’s global portfolio and seek acquisitions, licensing deals and partnerships in the United States – a new frontier for the France-based global pharmaceutical company.      Throughout his career, David has held leadership positions at several industry-leading companies, including Shire, Baxalta and Novartis. Most recently, he served as Shire’s Head of the Global Genetic Disease and Oncology franchises, where he oversaw the cross-functional leadership teams responsible for strategy, marketing, business assessment and planning. His career highlights include the approval of products for oncology (acute lymphoblastic leukemia and metastatic pancreatic cancer) and genetic diseases (hereditary angioedema). David also guided Servier’s acquisition of the Shire Oncology portfolio. Energized by his long-held mission to find cures for cancer and rare diseases, David spent time early in his career working at Partners in Health in Rwanda, the World Health Organization in Geneva and the Boston Medical Library. While at Novartis, he helped launch novel vaccines and orchestrated the successful cross-functional completion of three Phase I trials, two Phase II trials, and a Phase III registration trial. He has a passion for open innovation that feeds his commitment to identifying meaningful partnerships across the healthcare spectrum to foster next-generation scientific discovery that will have a lasting social impact in the United States and, ultimately, around the world. David received his Bachelor of Science in Biochemistry from Harvard University and later received his Master of Business Administration from Harvard Business School. Register soon because space is limited. We hope you’re able to join us! Tuesday, June 22, 2021 7:00 PM BIO Digital Taiwan Day Register Monte Jade New England xxx, NORTH EASTON, MA 02356 US Unsubscribe  |  Privacy Policy